Third Quarter 2024 Financial Results Cash Position: The Company’s cash position as of September 30, 2024, was $41.6 million compared to $9.4 million as of December 31, 2023.

HIGH POINT, N.C., Aug. 08, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (VTVT), a late-stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program ...

VTV will broadcast all 51 matches of UEFA EURO 2024 live, along with commentary programs before, during, and after the matches. In addition, VTV will organize special programs such as the Opening ...

Vietnamese football fans, who traditionally watch major tournaments on VTV, are eagerly anticipating the potential broadcast of EURO 2024 on VTV channels. EURO 2024 is scheduled to take place from ...

In March 2025, vTv Therapeutics announced that the clinical hold placed by the FDA in July 2024 on the cadisegliatin clinical program was lifted on March 14, 2025, following the Company's ...